ID   UM-3 [Human plasma cell myeloma]
AC   CVCL_W394
SY   UM3
DR   Wikidata; Q54990753
RX   PubMed=10087940;
RX   PubMed=10936422;
RX   PubMed=15257707;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
RX   PubMed=10087940; DOI=10.1016/S0165-4608(98)00157-5;
RA   Kuipers J., Vaandrager J.W., Weghuis D.O., Pearson P.L., Scheres J.,
RA   Lokhorst H.M., Clevers H.C., Bast B.J.E.G.;
RT   "Fluorescence in situ hybridization analysis shows the frequent
RT   occurrence of 14q32.3 rearrangements with involvement of
RT   immunoglobulin switch regions in myeloma cell lines.";
RL   Cancer Genet. Cytogenet. 109:99-107(1999).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//
RX   PubMed=15257707; DOI=10.1111/j.1365-2141.2004.05050.x;
RA   Boersma-Vreugdenhil G.R., Kuipers J., van Stralen E., Peeters T.,
RA   Michaux L., Hagemeijer A., Pearson P.L., Clevers H.C., Bast B.J.E.G.;
RT   "The recurrent translocation t(14;20)(q32;q12) in multiple myeloma
RT   results in aberrant expression of MAFB: a molecular and genetic
RT   analysis of the chromosomal breakpoint.";
RL   Br. J. Haematol. 126:355-363(2004).
//